Perisurgical physiopathology and pain
PRINCIPAL INVESTIGATORS
- Antònia Dalmau Llitjòs
- Sara Garcia Ballester
- Victor Mayoral Rojals
- Andrés Ancor Serrano Afonso
CLINICAL RESEARCHERS
- Carmina Ribes Llario
- Maylin Koo Gómez
- Marc Giménez Milà
- Marta Caballero Milán
- Ariadna Leon Moreno
POSTDOCTORAL RESEARCHERS
- Marta Costa Reverte
PREDOCTORAL RESEARCHERS
- Marta Barquero López
- Laura Viguera Fernández
Neuroscience
Neuroscience
Scientific production
17
PAPERS
Average IF: 2,75
9
LED PAPERS
Average IF: 2,44
2 PUBLICATIONS IN FIRST DECILE
3 PUBLICATIONS IN FIRST QUARTILE
8 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Garcia Casanovas,A;Bisbe,E;Garcia Altes,A;Vizoso,A;Duran Jorda,X;Sanchez Pedrosa,G;Barquero,M et al, Hospital variation in quality indicators for patient blood management in total knee and hip arthroplasty: a retrospective cohort study, Br. J. Anaesth., 2024;133(3):637-646, doi:10.1016/j.bja.2024.05.019
- Andrés Benito,P;Vázquez Costa,JF;Garzón,NCN;Colomina,MJ;Marco,C;González,L;Terrafeta,C et al, Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen, Int J Mol Sci, 2024;25(7):doi:10.3390/ijms25073810
- Blasi,A;Garcia Criado,A;Moreno Rojas,J;Perez Serrano,C;Ubre,M;Dieguez,I;Panzeri,M et al, A multicenter study of the risk of major bleeding in patients with and without cirrhosis undergoing percutaneous liver procedures., Liver Transpl, 2024;doi:10.1097/LVT.0000000000000447
- Roca Pereira,S;Domínguez,R;León,IM;Colomina,MJ;Yélamos,AM;Yélamos,SM;Povedano,M et al, Increased CXCL12, a potential CSF biomarker for differential diagnosis of amyotrophic lateral sclerosis, Brain Commun, 2024;6(4):doi:10.1093/braincomms/fcae271
- Borrego Hernández,D;Vázquez Costa,JF;Domínguez Rubio,R;Expósito Blázquez,L;Aller,E;Padró Miquel,A;García Casanova,P et al, Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population, Biomedicines, 2024;12(2):doi:10.3390/biomedicines12020356
Research highlights
PROJECTS
1 Ongoing competitive project
5 Started clinical trials
9 Ongoing clinical trials
PUBLISHED WORKS
1 Thesis
Selected projects
- 2019-003502-28. Estudio en grupos paralelos, doble ciego, aleatorizado y controlado por placebo, para evaluar la eficacia y seguridad de AP-325 en pacientes con Dolor Neuropático Periférico Post-quirúrgico. Algiax Pharmaceuticals GmbH. Budget: 34.860€. 2020- . PI: Andrés Ancor Serrano Afonso.
- 2022-131-1. Ensayo clínico de intervención en fase iii, multicéntrico, aleatorizado, con doble enmascaramiento, controlado y con grupos paralelos para confirmar la eficacia y la seguridad de Qutenza®en pacientes con Dolor Neuropático Posquirúrgico. AVERITAS PHARMA, INC. Budget: 30.312€. 2022- . PI: Andrés Ancor Serrano Afonso.
- 2023-507358-34-00. Multicenter, doublé-blind, randomized, placebo-controlled, dose response trial with the full-spectrum Cannabis Extract VER-01 in patients with chronic non-specific low back pain.. Vertanical GmbH. Budget: 12.584,01€. 2024- . PI: Andrés Ancor Serrano Afonso.
- PSJ23039. Artificial intelligence (AI) to facilitate surgery. Use Case Proofof-Concept in Breast Cancer Surgery for a New Innovative Artificial Intelligence Automated Pre- Anesthesia Risk Assessment Tool. Jané Mateu Foundation. Budget: 6.000€. 2023-2024. PI: Colomina Soler, Maria Jose.
- 2023-223-1. POSTOPERATIVE PULMONARY COMPLICATIONS IN EMERGENCY ABDOMINAL SURGERY. INCIDENCE AND RISK FACTORS. A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY. Hospital Clínic de Barcelona. 2023- . PI: Marta Costa Reverte.